Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Following a major outbreak involving the use of tear drops in 13 US states, experts are offering advice on how to protect dry eyes.
Read Full NewsClinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.
Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.
Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.
The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.
1.
Does diabetes impact the prognosis of people with colorectal cancer?
2.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
The need for more Latinx participants in Alzheimer's trials is urgent.
5.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
1.
Anemia in Older Adults: Causes, Clinical Impact, and Evidence-Based Management
2.
Managing Acute Respiratory Failure in Hematological Malignancies
3.
Understanding Histiocytosis: Symptoms, Causes, and Treatment Options
4.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
5.
Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
3.
Current Scenario of Cancer- Q&A Session to Close the Gap
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge